Literature DB >> 6448268

Spectrum of immunodeficiencies with Hodgkin's disease.

J J Twomey, A H Laughter, L Rice, R Ford.   

Abstract

The role of six suppressor mechanisms upon T and B cell responses was studied on 17 untreated patients with Hodgkin's disease. Proliferative hyporesponsiveness to mitogen was greatly impaired in 8 of the 13 patients. 10 of these patients had an excessive degree of suppression by cells that adhered to foreign surfaces. Suppression by adherent cells correlated with impairment of proliferative responses and, in some instances, suppression was largely inhibited with indomethacin. Likewise, adherent cells suppressed immunoglobulin synthesis. A correlation was evident between suppression of T and B cell responses by adherent mononuclear leukocytes from individual patients. This suppression coincided with elevated percentages of monocytes in the patient mononuclear cell preparations. This excess of monocytes was not the result of a circulating monocytosis. The monocyte excess may have been acquired during isopyknic cell separation. A second form of suppression was observed in 5 of the 11 patients affected by a lymphocyte that neither adhered to glass wool nor required preactivation. It did not inhibit allogeneic lymphocytes, which contrasts with the suppressor abnormality of monocytoid cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448268      PMCID: PMC371635          DOI: 10.1172/JCI109898

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.

Authors:  W H Churchill; R R Rocklin; W C Moloney; J R David
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

2.  The splenic suppressor cell. I. Activity of thymus-dependent adherent cells: changes with age and stress.

Authors:  H Folch; B H Waksman
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients.

Authors:  R C Young; M P Corder; H A Haynes; V T DeVita
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

5.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

6.  Cellular requirements for the mitotic response in allogeneic mixed leukocyte cultures.

Authors:  J J Twomey; O Sharkey; J A Brown; A H Laughter; P H Jordan
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

7.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

8.  Impaired lymphocyte function in untreated Hodgkin's disease.

Authors:  R Levy; H S Kaplan
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

9.  An extracorporeal device to treat barbiturate poisoning. Use of anion-exchange resins in dogs.

Authors:  T F Nealon; H Sugerman; W Shea; E Fleegler
Journal:  JAMA       Date:  1966-07-11       Impact factor: 56.272

10.  Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia.

Authors:  G Holm; P Perlmann; B Johansson
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

View more
  11 in total

1.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Discordant lymphoma: a case report.

Authors:  J Coyne; W F Kealy; J Hogan; C Murphy
Journal:  Ir J Med Sci       Date:  1987-03       Impact factor: 1.568

3.  Defective in vitro antibody production to Varicella zoster and other virus antigens in patients with Hodgkin's disease.

Authors:  R L Souhami; J Babbage; A Sigfusson
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

4.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.

Authors:  J Passwell; M Levanon; J Davidsohn; B Ramot
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

6.  Effect of sera from patients with Hodgkin's disease on normal donor lymphocytes containing parallel tubular structures.

Authors:  J W Smit; N R Blom; M J van Luyn; G W van Imhoff; M R Halie
Journal:  Blut       Date:  1984-02

7.  Role of lymphocyte blastogenesis to Toxoplasma gondii antigens in containment of chronic, latent T. gondii infection in humans.

Authors:  R McLeod; R G Estes
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

8.  Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.

Authors:  R D Deshazo; C Ewel; S Londono; Z Metzger; J T Hoffeld; J J Oppenheim
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

9.  Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's disease.

Authors:  A Sigfusson; J W Babbage; R L Souhami
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

10.  A comparison of the regulatory effects of human monocytes, pulmonary alveolar macrophages (PAMs) and spleen macrophages upon lymphocyte responses.

Authors:  J J Twomey; A Laughter; M F Brown
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.